Supporting pediatric cancer survivors with neurocognitive late effects: a model of care

Area of Science:

• Pediatric Oncology
• Neuroscience
• Educational Psychology

Background:

• Childhood cancer survivors, particularly those with central nervous system (CNS) involvement, frequently experience neurocognitive late effects.
• These effects can manifest as difficulties in attention, executive functioning, processing speed, academic performance, and social integration, leading to social isolation.
• Effective educational support is crucial for this vulnerable population to mitigate long-term challenges.

Purpose of the Study:

• To provide an overview of a School Liaison Program (SLP) model designed to address the educational needs of pediatric patients treated for CNS cancers.
• To evaluate the parent-perceived quality and effectiveness of the SLP in supporting children with cancer-related neurocognitive deficits.
• To highlight the importance of tailored interventions for academic and social success in childhood cancer survivors.

Main Methods:

• Descriptive overview of the School Liaison Program (SLP) model of care.
• Inclusion of parent-reported feedback on program quality and effectiveness.
• Analysis of perceived impacts on academic performance, home-school communication, and school understanding of student needs.

Main Results:

• Parents generally attributed positive outcomes to SLP involvement.
• Reported improvements included enhanced academic performance and better home-school communication.
• Parents also noted increased understanding at the school level regarding their child's unique cognitive profiles and learning requirements.

Conclusions:

• The School Liaison Program (SLP) model demonstrates effectiveness in supporting childhood cancer survivors with CNS involvement.
• Parental perception indicates significant benefits in academic achievement and collaborative school-family-medical partnerships.
• The SLP plays a vital role in addressing the complex educational and psychosocial needs of pediatric cancer patients, promoting better integration and success.